Lansoprazol Orifarm may be available in the countries listed below.
Ingredient matches for Lansoprazol Orifarm
Lansoprazole is reported as an ingredient of Lansoprazol Orifarm in the following countries:
- Denmark
International Drug Name Search
Lansoprazol Orifarm may be available in the countries listed below.
Lansoprazole is reported as an ingredient of Lansoprazol Orifarm in the following countries:
International Drug Name Search
Treating certain worm infections (eg, pinworm, roundworm).
Reese's Pinworm Medicine is an anthelmintic agent. It works by paralyzing the nervous system of intestinal parasites (worms). The parasite is then passed in the stool.
Contact your doctor or health care provider right away if any of these apply to you.
Some medical conditions may interact with Reese's Pinworm Medicine. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:
Some MEDICINES MAY INTERACT with Reese's Pinworm Medicine. Tell your health care provider if you are taking any other medicines, especially any of the following:
This may not be a complete list of all interactions that may occur. Ask your health care provider if Reese's Pinworm Medicine may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.
Use Reese's Pinworm Medicine as directed by your doctor. Check the label on the medicine for exact dosing instructions.
Ask your health care provider any questions you may have about how to use Reese's Pinworm Medicine.
All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:
Diarrhea; dizziness; drowsiness; headache; loss of appetite; nausea; stomach cramps; trouble sleeping; vomiting.
Severe allergic reactions (rash; hives; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue).
This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.
See also: Reese's Pinworm Medicine side effects (in more detail)
Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately.
Store Reese's Pinworm Medicine at room temperature, between 59 and 86 degrees F (15 and 30 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Keep Reese's Pinworm Medicine out of the reach of children and away from pets.
This information is a summary only. It does not contain all information about Reese's Pinworm Medicine. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.
Treating symptoms associated with a certain bladder problem (interstitial cystitis). It may also be used for other conditions as determined by your doctor.
Dimethyl Sulfoxide is a sterile solution of dimethyl sulfoxide. It is unknown exactly how Dimethyl Sulfoxide works.
Contact your doctor or health care provider right away if any of these apply to you.
Some medical conditions may interact with Dimethyl Sulfoxide. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:
Some MEDICINES MAY INTERACT with Dimethyl Sulfoxide. However, no specific interactions with Dimethyl Sulfoxide are known at this time.
This may not be a complete list of all interactions that may occur. Ask your health care provider if Dimethyl Sulfoxide may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.
Use Dimethyl Sulfoxide as directed by your doctor. Check the label on the medicine for exact dosing instructions.
Ask your health care provider any questions you may have about how to use Dimethyl Sulfoxide.
All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:
Bladder discomfort; garlic odor on breath or skin for up to 72 hours; garlic taste for several hours.
Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); eye pain or burning; vision changes.
This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.
See also: Dimethyl Sulfoxide side effects (in more detail)
Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately.
Store Dimethyl Sulfoxide at room temperature, between 59 and 86 degrees F (15 and 30 degrees C). Store away from heat, moisture, and light. Protect from light. Do not store in the bathroom. Keep Dimethyl Sulfoxide out of the reach of children and away from pets.
This information is a summary only. It does not contain all information about Dimethyl Sulfoxide. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.
Clarus may be available in the countries listed below.
Isotretinoin is reported as an ingredient of Clarus in the following countries:
International Drug Name Search
Ridinox may be available in the countries listed below.
Idoxuridine is reported as an ingredient of Ridinox in the following countries:
International Drug Name Search
Class: Vitamin B Complex
ATC Class: A11HA04
VA Class: VT106
CAS Number: 83-88-5
Water-soluble, B complex vitamin.a b
Used to prevent and treat riboflavin deficiency (ariboflavinosis).a b
Riboflavin deficiency may occur in patients with long-standing infections, liver disease, alcoholism, malignancy, cardiac disease, diabetes mellitus, and those taking probenecid.a
Adequate intake needed to prevent riboflavin deficiency (ariboflavinosis).101 b
Adequate intake of riboflavin usually can be accomplished through consumption of foodstuffs, including milk, bread products, and fortified cereals.101 b
Estimated Average Requirement (EAR) and Recommended Dietary Allowance (RDA) in adults based on a combination of criteria including erythrocyte glutathione reductase activity and urinary excretion of riboflavin.101 b
Adequate intake (AI) established for infants ≤6 months of age based on riboflavin intake of infants fed principally human milk;b AI for infants 7–12 months of age based on the AI for younger infants and data from adults.b
EAR and RDA for children 1–18 years of age based on data in adults.101 b
Used as a urine marker when mixed with various drugs to test for patient compliance with the therapeutic regimen of these drugs.a
Has been used for prophylaxis of migraine headache† to decrease the frequency and duration of attacks.102
Correct poor dietary habits and consider a multivitamin preparation containing riboflavin in patients with vitamin deficiencies since poor dietary habits often result in concurrent deficiencies.a
Administer orally.a e
May be given by IM injection or IV infusion as a component of a multivitamin injection.a A parenteral formulation containing riboflavin alone is not currently commercially available.a
Administer orally, preferably with food.e
Usually, 3–10 mg daily.a
Infants <6 months of age: AI is 0.3 mg (0.04 mg/kg) daily.101
Infants 6–12 months of age: AI is 0.4 mg (0.04 mg/kg) daily.101
Children 1–3 years of age: RDA is 0.5 mg daily.101
Children 4–8 years of age: RDA is 0.6 mg daily.101
Children 9–13 years of age: RDA is 0.9 mg daily.101
Girls 14–19 years of age: RDA is 1 mg daily.101
Boys 14–19 years of age: RDA is 1.3 mg daily.101
Usually, 5–30 mg daily given in divided doses.a
Patients with normocytic, normochromic anemia: 10 mg daily usually increases reticulocyte count within a few days.a
Women ≥19 years of age: RDA is 1.1 mg daily.101
Men ≥19 years of age: RDA is 1.3 mg daily.101
These RDAs will not meet the needs of individuals with severe malabsorption.101 b
400 mg daily; maximal benefit may occur after 3 months of prophylaxis therapy.102
Pregnant women: RDA is 1.4 mg daily.101 Riboflavin intake exceeding this RDA may be needed by women who are pregnant with more than one fetus.101 b
Lactating women: RDA is 1.6 mg daily.101 Riboflavin intake exceeding this RDA may be needed by mothers nursing more than one infant.101 b
May require additional riboflavin intake in patients who are extremely physically active.b
Patients undergoing hemodialysis or peritoneal dialysis may require additional riboflavin.b
Known hypersensitivity to riboflavin or any ingredient in the formulation.c
Increased riboflavin deficiency risk in patients with cancer, cardiac disease, or diabetes mellitus.b
Consider the cautions, precautions, and contraindications associated with other drug(s) and vitamins in fixed-combination preparations.c
Category A.d Category C (for dosages >RDA).d (See Special Populations under Dosage and Administration.)
Distributed into human milk.101 a d
Usually nontoxic even in large doses.a b
Drug or Test | Interaction | Comments |
---|---|---|
Aminoglyosides (kanamycin, streptomycin) | Possible decreased antibiotic activity c | |
Bleomycin | Inactivated in vitro by riboflavinc | |
Erythromycin | Possible decreased antibiotic activity c | |
Probenecid | Decreased absorption of riboflavina | |
Propantheline | Propantheline may delay the rate of riboflavin absorption, but increase the total amount absorbed a | |
Spectrometry or color reaction urinalysis | Possible color interferencea | |
Tests for catecholamines | Possible false elevations in fluorometric determinations of plasma or urinary catecholaminesa | |
Tests for urobilinogen | Possible false elevations in fluorometric determinations of plasma or urinary urobilinogena |
Readily absorbed from the upper GI tract.a b Rate of absorption is proportional to intake.b
Therapeutic response in riboflavin-deficient patients may require several days for ocular and dermatologic manifestations of deficiency to improve.a
Following oral administration in deficient patients with normocytic, normochromic anemia, an increase in reticulocyte count usually occurs within a few days.a
Food increases extent of absorption.a b
Extent of absorption is decreased in patients with hepatitis, cirrhosis, or biliary obstruction.a
Widely distributed into most tissues, including GI mucosal cells, erythrocytes, and the liver as riboflavin 5-phosphate (flavin mononucleotide [FMN]) and flavin adenine dinucleotide (FAD).a b Free riboflavin is present in the retina.a
Stored in limited amounts in the liver, spleen, kidneys, and heart, mainly as FAD.a
Crosses the placenta and is distributed into milk.101
About 60% as FAD and FMN.a
Phosphorylated to FMN in GI mucosal cells, erythrocytes, and the liver; FMN is converted to FAD in the liver.a
Urine (about 9%) as unchanged drug; fate of the remainder of the dose not determined.a
Following oral or IM administration, about 66–84 minutes.a
Removal by hemodialysis is slower than normal renal excretion.a
In neonates, urinary excretion is slow; however, the cumulative amount excreted is similar to the amount excreted by older infants.b
Tight, light-resistant containers at 15–30°C.a
For information on systemic interactions resulting from concomitant use, see Interactions.
Incompatible with alkaline solutions.a
An exogenous source of riboflavin is required for tissue respiration.a
Converts to coenzymes (FMN and FAD) involved in oxidation-reduction reactions of organic substrates and in intermediary metabolism.a b e
Flavocoenzymes are involved in the formation of some vitamins and their coenzymes, including niacin, vitamin B6, and vitamin B12.101 b
Indirectly involved in maintaining erythrocyte integrity.a
Importance of proper dietary habits, including taking appropriate AI or RDA of vitamin B2.
Inform patients that large doses of riboflavin can result in bright yellow urine.a
Importance of women informing clinicians if they are or plan to become pregnant or plan to breast-feed.b
Importance of informing clinicians of existing or contemplated concomitant therapy, including prescription and OTC drugs.b
Importance of informing patients of other important precautionary information. (See Cautions.)
Excipients in commercially available drug preparations may have clinically important effects in some individuals; consult specific product labeling for details.
Riboflavin, riboflavin 5-phosphate, and riboflavin 5-phosphate sodium are also commercially available in combination with other vitamins, minerals, amino acids, cerebral stimulants, protein supplements, infant formulas, enzymes, hormones, sedatives, laxatives, and unsaturated fatty acids.a For IM injection, riboflavin is commercially available in combination with other vitamins and iron.a For IV infusion, riboflavin is commercially available in combination with other vitamins.a c
* available from one or more manufacturer, distributor, and/or repackager by generic (nonproprietary) name
Routes | Dosage Forms | Strengths | Brand Names | Manufacturer |
---|---|---|---|---|
Bulk | Powder* | |||
Oral | Capsules | 100 mg* | ||
Tablets | 25 mg* | |||
50 mg* | ||||
100 mg* | ||||
Sublingual | Tablets | 25 mg (as flavin mononucleotide [coenzymated])* | Riboflavin Sublingual Tablets |
This report on medications is for your information only, and is not considered individual patient advice. Because of the changing nature of drug information, please consult your physician or pharmacist about specific clinical use.
The American Society of Health-System Pharmacists, Inc. and Drugs.com represent that the information provided hereunder was formulated with a reasonable standard of care, and in conformity with professional standards in the field. The American Society of Health-System Pharmacists, Inc. and Drugs.com make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information and specifically disclaims all such warranties. Users are advised that decisions regarding drug therapy are complex medical decisions requiring the independent, informed decision of an appropriate health care professional, and the information is provided for informational purposes only. The entire monograph for a drug should be reviewed for a thorough understanding of the drug's actions, uses and side effects. The American Society of Health-System Pharmacists, Inc. and Drugs.com do not endorse or recommend the use of any drug. The information is not a substitute for medical care.
AHFS Drug Information. © Copyright, 1959-2011, Selected Revisions August 01, 2009. American Society of Health-System Pharmacists, Inc., 7272 Wisconsin Avenue, Bethesda, Maryland 20814.
† Use is not currently included in the labeling approved by the US Food and Drug Administration.
Only references cited for selected revisions after 1984 are available electronically.
100. National Research Council Food and Nutrition Board Subcommittee on the Tenth Edition of the RDAs. Recommended dietary allowances. 10th ed. Washington, DC: National Academies Press; 1989:132-7.
101. Standing Committee on the Scientific Evaluation of Dietary Reference Intakes of the Food and Nutrition Board, Institute of Medicine, National Academy of Sciences. Dietary reference intakes for thiamin, riboflavin, niacin, vitamin B6, folate, vitamin B12, pantothenic acid, biotin, and choline. Washington, DC: National Academies Press; 1998.
102. Schoenen J, Jacquy J, Lenaerts M. Effectiveness of high-dose riboflavin in migraine prophylaxis: a randomized controlled trial. Neurology. 1998; 50:466-70. [IDIS 401485] [PubMed 9484373]
a. AHFS Drug Information 2009. McEvoy GK, ed. Riboflavin. Bethesda, MD: American Society of Health-System Pharmacists; 2009.
b. Otten JJ, Hellwig JP, Meyers LD, eds. Dietary reference intakes: the essential guide to nutritional requirements. Washington, DC: National Academies Press; 2006.
c. Baxter. INFUVITE Adult (Multiple vitamins for Infusion) prescribing information. Deerfield, IL; 2004 May.
d. Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation. 7th ed. Baltimore , MD: Williams & Wilkins; 2005:1410–11.
e. Nature’s Way. Vitamin B2 (riboflavin) capsules product information. Springville, UT; 2004.
Movipride may be available in the countries listed below.
Bromopride is reported as an ingredient of Movipride in the following countries:
International Drug Name Search
Theophyllin Lindopharm may be available in the countries listed below.
Theophylline is reported as an ingredient of Theophyllin Lindopharm in the following countries:
International Drug Name Search
Alprazolam Unilan may be available in the countries listed below.
Alprazolam is reported as an ingredient of Alprazolam Unilan in the following countries:
International Drug Name Search